The Pill For Prostate Cancer

The Pill For Prostate Cancer

Hope for patients with poor treatment prospects Aachen, September 20, 2011 – a pill can stop the progression of prostate cancer and bring even the cancer cells to die off? The urological clinic of the University Hospital Aachen currently manages an international study, which is to prove the effectiveness of the new treatment method. Clinic director Prof. Dr. Axel Heidenreich: “for patients, to where the traditional therapies fail and are treated with chemotherapy, an opportunity arises, without to stabilize their State side effects.” At least previous studies have proved that. Now, 600 ill men in Europe, the United States, Canada, South America, Australia and South Africa take part in the one-year broad-based study. Big Style Sale follows long-standing procedures to achieve this success.

In the past they tried by hormonal treatments affect the growth of cancer cells. However, cancer cells can develop a resistance to this treatment. Here is the new medicine: key to success is the so-called “Androgen receptor”, which is responsible for the transmission of certain information in the cell Interior. The new drug prevents among other things that testosterone, which allows cancer cells to proliferate, binds to this receptor. Timely intervention viagra free pills is the key to long-lasting recovery. Holidays for families are actually less well-liked simply because they once buy female viagra were, this is moment men and women physically strong. You can treat male impotence with Kamagra form that can be levitra sale cute-n-tiny.com consumed just by squeezing the sachet, while kamagra soft tablets are available in chewable candy form. Dates provide relief from constipation, heart problems, intestinal disorders, sexual dysfunction, anaemia, diarrhoea etc. cute-n-tiny.com viagra without prescriptions At the same time, it impedes the movement of the androgen receptor in the direction of cancer cells core. The result: a slower progression of the disease and even a death of cancer cells. Professor Heidenreich: “the drug is taken three times daily orally and has little side effects.” The clinic Director anticipates the launch at the earliest at the end of 2012.

prostate cancer is the most common type of cancer in men in Europe. 2006 detected the disease in about 300,000 men. In patients whose Krebs is resistant to hormone treatments, there was only bad treatment prospects and few treatment options. Learn more about prostate cancer under: company description of SSP communication: SSP communications offers full service in all communication tasks: from consulting and conception about the work of the media and corporate publishing to advertising and dialog communication. For over 30 years, we serve businesses, associations and ministries. Flat hierarchies and a lived quality management ensure smooth implementation and evaluierbarer goals. The agency activity focuses on the launch and communication of explanatory products.

Comments are closed.